Life Sciences BC Announces Selected Companies and Mentors for Seventh Annual Investor Readiness Program

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Life Sciences BC Announces Selected Companies and Mentors for Seventh Annual Investor Readiness ProgramAuthor of the article:VANCOUVER, British Columbia — Life Sciences BC (LSBC) is proud to announce the companies selected for its 2027 Investor Readiness Program (IRP). The IRP is a six-month program designed to prepare emerging British Columbia (B.C.) life sciences ventures for capital attraction and is aimed to accelerate company growth.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountThe IRP connects promising Small and Midsize Enterprises (SMEs) with established Entrepreneurs‑in‑Residence (EIRs) who bring decades of experience in venture capital, commercialization, and executive leadership. Together, they work to advance each company’s investment strategies, refine business models, and strengthen access to capital.This advertisement has not loaded yet, but your article continues below.The following companies been selected for the 2027 IRP cohort:Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againChondros BioCore Motion Inc.ImmunoWell LabsMiha BiotechNellaDerm TherapeuticsNovapars Discovery Inc.NTP R&D Services Ltd.Resilience Biosciences Inc.Total LifeAdditionally, a stealth biotech company was also selected.These companies have been paired with the following mentors:Chondros Bio with Malcolm Kendall, Founding Partner, CDG VenturesCore Motion Inc. with Geof Auchinleck, CEO, Claris HealthcareImmunoWell Labs with Jason Roberston, Co-Founder and CEO, Nimbus Synergies Inc.Miha Biotech with Norma Sebestyen, Consultant, Life Sciences ExecutiveStealth Biotech Company with Nancy Harrison, Venture Partner, Amplitude VenturesNellaDerm Therapeutics with Paul Brennan, Chief Corporate Development Officer, EupraxiaNovapars Discovery Inc. with Allison Gaw, Partner, Amplitude VenturesNTP R&D Services Ltd. with Lu Han, Partner, Lumira VenturesResilience Biosciences Inc. with Anne Stevens, Life Sciences ExecutiveTotal Life with Brenda Irwin, Managing Partner, Relentless Venture FundThroughout the program, running from October to March, participants receive personalized coaching, strategic goal‑setting guidance, and tailored education sessions. The experience culminates in a final pitch event where each company presents to investors and key stakeholders from B.C.’s life sciences community.The Investor Readiness Program is supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).“I’m excited to be part of Life Sciences BC’s Investor Readiness Program because it provides exactly the kind of bridge early-stage life science companies need: focused mentorship, investor perspective, and a clearer path from strong science to real-world impact. For Resilience Biosciences, this is an important opportunity to sharpen our strategy as we advance non-opioid therapeutics for the biological barriers to recovery from opioid use disorder.”— Lily Aleksandrova, Product Development & Compliance Director, Resilience Biosciences Inc.“We are delighted to have the support of Life Sciences BC to help us accelerate our mission of to provide timely mental health support and longevity care to older adults globally.”— Neelam Brar, CEO, Total Life“I love the Investor Readiness Program because I get to roll up my sleeves with ambitious founders tackling important problems. This year’s 1:1 match is particularly close to my heart: an entrepreneur working to improve mental health in older adults. I can’t wait to get started. And of course, to share my infamous VC101 content with all the participants!”This advertisement has not loaded yet, but your article continues below.— Brenda Irwin, Entrepreneur‑in‑Residence, Managing Partner, Relentless Venture Fund“We’re excited to join Life Sciences BC’s Investor Readiness Program as we work to move treatment for inflammatory skin diseases beyond trial and error. The program’s mentorship and industry connections will help us strengthen our fundraising approach and advance NellaDerm’s vision.”— Sajjad Janfaza, CEO, NellaDerm Therapeutics“Chondros Bio is at an exciting inflection point as we move OsteoChon from the lab toward the clinic. The Investor Readiness Program gives us the coaching, investor access and B.C. community support to raise the capital we need to get there.”— Bob Mighell, Founder & CEO, Chondros BioLife Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia’s life sciences ecosystem. LSBC represents more than 280 members across industry, academia, government, service providers, and associated organizations. Strengthening the sector, LSBC fosters collaboration, facilitates partnerships and investment, and develops talent. LSBC promotes and brings national and international visibility to the sector through various initiatives. Through this work, LSBC helps create opportunities for innovation, economic growth, and solutions that can improve health outcomes and patients’ lives.View source version on businesswire.com: Director, Business Operations and ProgramsThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.